InvestorsObserver
×
News Home

How Will the Market React to Hologic, Inc. (HOLX) Stock Getting a Bullish Rating

Friday, December 01, 2023 03:38 PM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Hologic, Inc. (HOLX) Stock Getting a Bullish Rating

Overall market sentiment has been high on Hologic, Inc. (HOLX) stock lately. HOLX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Hologic, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on HOLX!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With HOLX Stock Today?

Hologic, Inc. (HOLX) stock is down -0.11% while the S&P 500 has risen 0.57% as of 3:33 PM on Friday, Dec 1. HOLX has fallen -$0.08 from the previous closing price of $71.30 on volume of 712,237 shares. Over the past year the S&P 500 is higher by 12.59% while HOLX has fallen -6.49%. HOLX earned $1.83 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 38.82. To see InvestorsObserver's Sentiment Score for Hologic, Inc. click here.

More About Hologic, Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. Click Here to get the full Stock Report for Hologic, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App